Proton Pump Inhibitors: all 885 studies that test it
Page 7 of 9. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male SubjectsCompletedNCT01494402Phase 1
- Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic EsophagitisWithdrawnNCT01479231Phase 1/2
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBICWithdrawnNCT01471925Phase 3
- Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)CompletedNCT01470690Phase 1
- 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori EradicationStatus unknownNCT01464060Phase 4
- Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male SubjectsCompletedNCT01415128Phase 1
- ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASACompletedNCT01408186Phase 3
- Effects of Gastric pH on the Pharmacokinetics of DasatinibCompletedNCT01398046Phase 1
- A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy VolunteersCompletedNCT01392755Phase 1
- Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERDWithdrawnNCT01391715Phase 3
- Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult VolunteersCompletedNCT01358383Phase 1
- BRAVO Study for Functional DyspepsiaCompletedNCT01349413Phase 4
- A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)CompletedNCT01337804Phase 1
- H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot StudyStatus unknownNCT01335334Phase 4
- Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil HypertrophyStatus unknownNCT01328652Phase 4
- Evaluating Treatment Response in Laryngo-Pharyngeal RefluxWithdrawnNCT01328392Not applicable
- Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori EradicationCompletedNCT01306786Not applicable
- BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
- A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the TabletCompletedNCT01287091Phase 1
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01283932Phase 1
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283919Phase 1
- CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
- A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic TherapyStatus unknownNCT01275937Phase 4
- Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical PracticeCompletedNCT01273441Phase 4
- Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting ConditionsCompletedNCT01270308Phase 1
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical TrialCompletedNCT01269788Phase 2/3
- Impact of Omeprazole and Fluvoxamine on Platelet Response to ClopidogrelCompletedNCT01269333Phase 1
- A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult VolunteersCompletedNCT01241409Phase 1
- A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori InfectionCompletedNCT01219764Phase 4
- Evaluation of Methods for the Determination of Chromogranin A in Routine Blood SamplesCompletedNCT01216267Not applicable
- An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of ClopidogrelCompletedNCT01210339Phase 1
- Study to Evaluate the Interaction Between Aspirin and NexiumCompletedNCT01199328Phase 1
- Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of CytochromesCompletedNCT01187862Phase 1
- A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult VolunteersCompletedNCT01186497Phase 1
- Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic HemostasisStatus unknownNCT01182597Phase 3
- PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding UlcersCompletedNCT01180179Phase 4
- Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled TrialStatus unknownNCT01179724Not applicable
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed ConditionsCompletedNCT01179659Phase 1
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg TabletsCompletedNCT01179646Phase 1
- Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed ConditionCompletedNCT01170182Phase 1
- Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting ConditionsCompletedNCT01170169Phase 1
- Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid TumoursCompletedNCT01163903Phase 1
- Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mgCompletedNCT01163630Phase 1
- Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male SubjectsCompletedNCT01159145Phase 1
- A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg TabletsCompletedNCT01153659Phase 1
- Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety EvaluationCompletedNCT01150162Phase 3
- Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive HeartburnCompletedNCT01149395Phase 1
- Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCompletedNCT01147588Phase 1
- Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic TherapyCompletedNCT01142245Phase 3
- A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal InjuryCompletedNCT01140828Phase 3
- Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese SubjectsCompletedNCT01136317Phase 2
- Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy VolunteersCompletedNCT01135472Phase 1
- Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT01132638Phase 3
- Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori EradicationCompletedNCT01131026Phase 3
- Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.Status unknownNCT01129713Phase 1/2
- Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)WithdrawnNCT01123031Phase 4
- EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal BleedingCompletedNCT01112852Phase 4
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsStatus unknownNCT01107938Phase 2
- A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult VolunteersCompletedNCT01101646Phase 1
- A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose AspirinCompletedNCT01094483Phase 1
- Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERDStatus unknownNCT01089959Phase 2/3
- A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)CompletedNCT01085708Phase 1
- Study of E3810 for Healthy Japanese Male (Under Fasting Condition)CompletedNCT01085695Phase 1
- Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in ChildrenCompletedNCT01082029Phase 4
- Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving PerformanceCompletedNCT01079884Not applicable
- Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With AspirinCompletedNCT01062516Phase 4
- Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse EvaluationCompletedNCT01051388Phase 3
- Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting ConditionsCompletedNCT01045642Phase 1
- Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed ConditionsCompletedNCT01045434Phase 1
- Lansoprazole for Subgroups of Functional DyspepsiaTerminatedNCT01040455Phase 4
- Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ AssayStatus unknownNCT01023360Phase 4
- Clopidogrel Proton-Pump Inhibitors StudyWithdrawnNCT01016717Phase 4
- Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken SeparatelyTerminatedNCT01015729Phase 1
- TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy VolunteersCompletedNCT01001247Phase 1
- Evaluation of Omeprazole Effect on GlaucomaStatus unknownNCT01000220Phase 1
- The Effect of Esomeprazole and Fundoplication on AirwaysCompletedNCT00994708Phase 3
- Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn AloneCompletedNCT00992381Phase 1
- The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
- Development of Cocktail for Measuring the Activity of Important Cytochrome P450 EnzymesTerminatedNCT00981929Not applicable
- Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer DyspepsiaStatus unknownNCT00978159Phase 4
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)CompletedNCT00953381Phase 2
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)CompletedNCT00952978Phase 3
- Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy SubjectsCompletedNCT00952913Phase 1
- Gastric Functions & Proton Pump Inhibitor( PPI) StudyCompletedNCT00951431Phase 4
- Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or FamotidineCompletedNCT00950339Phase 4
- A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 MetabolizersCompletedNCT00931073Phase 1
- Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
- H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal ResectionStatus unknownNCT00926809Phase 4
- Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy VolunteersCompletedNCT00915239Not applicable
- Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn ECompletedNCT00907400Phase 1
- Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer RebleedingWithdrawnNCT00881413Phase 4
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal RefluxCompletedNCT00864396Phase 1
- Prevention of Esophageal Variceal RebleedingStatus unknownNCT00863837Phase 4
- Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal BleedingStatus unknownNCT00861640Phase 4
- A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)CompletedNCT00855361Phase 1
- Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump InhibitorStatus unknownNCT00854776Not applicable
- Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori InfectionCompletedNCT00854451Phase 4
- A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
- Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal ResectionCompletedNCT00844675Phase 4
- Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/ErosionCompletedNCT00843063Phase 4